Editorial: A Step Back to Leap Forward—Strategic Nucleos(t)ide Analogue Discontinuation Towards HBV Functional Cure
Alimentary Pharmacology & Therapeutics · 2026-01 · 63 (2) · 303-305
DOI: 10.1111/apt.70352 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, published online on 2025-09-02. Written by Xuwen Xu and 2 co-authors. Institution: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Cited 2 times so far (Crossref); 10 references.
Abstract (original language)
Treatment discontinuation in patients with chronic hepatitis B (CHB) may be a viable strategy to achieve functional cure in selected individuals. However, concerns about relapse and safety remain. This study by Hume et al. provides valuable data on nu-cleos(t)ide analogue (NA) discontinuation in hepatitis B e antigen (HBeAg)- negative CHB patients [1]. A low end- of-treatment hepatitis B surface antigen (HBsAg) level ( ≤ 10 IU/mL) predicted earlier seroclearance with minimal hepatitis flares, whereas higher levels were linked to delayed seroclearance and flares. These findings highlight the clinical utility of HBsAg quantification at treatment cessation
Authors and institutions
- Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- State Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial…
Cite
APA
Xu, X., Lu, A., & Cai, S. (2026). Editorial: A Step Back to Leap Forward—Strategic Nucleos(t)ide Analogue Discontinuation Towards HBV Functional Cure. Alimentary Pharmacology & Therapeutics, 63(2), 303-305. https://doi.org/10.1111/apt.70352
Vancouver
Xu X, Lu A, Cai S. Editorial: A Step Back to Leap Forward—Strategic Nucleos(t)ide Analogue Discontinuation Towards HBV Functional Cure. Alimentary Pharmacology & Therapeutics. 2026;63(2):303-305. doi:10.1111/apt.70352
BibTeX
@article{Xu2026,
author = {Xu, Xuwen and Lu, Aili and Cai, Shaohang},
title = {Editorial: A Step Back to Leap Forward—Strategic Nucleos(t)ide Analogue Discontinuation Towards HBV Functional Cure},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {2},
pages = {303--305},
doi = {10.1111/apt.70352}
}
EUVIMED